Navigation Links
Improved Allergy Shots Might Be on Horizon
Date:11/3/2011

THURSDAY, Nov. 3 (HealthDay News) -- Allergy shots are time-tested treatments that reduce health care costs and can now provide relief to allergy sufferers within weeks instead of months, according to experts.

And while allergy shots are currently given under the skin (subcutaneously), new methods of allergy immunotherapy are being investigated, delegates heard at this week's annual scientific meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Boston.

Those potential new techniques include:

  • Intralymphatic immunotherapy (ILIT), which involves injecting allergens into a lymph node. Initial research shows that this approach provides a longer-lasting and more effective response, suggesting the dose and length of treatment could be shortened.
  • Epicutaneous immunotherapy (EPIT) involves lightly scraping a patient's skin and then applying a patch that delivers the allergens through the bloodstream.

Accelerated allergy immunotherapy and the cost benefits of immunotherapy were also discussed at the meeting.

Conventional immunotherapy requires patients to receive an allergy shot once or twice a week for about five months. But "rush" and "cluster" immunotherapy methods feature accelerated schedules to shorten that treatment period.

Rush immunotherapy typically involves giving multiple injections to a patient two or three days in a row, but schedules may be shorter or longer based on circumstances. Cluster immunotherapy involves two to four injections, given 30 minutes apart, one day a week for three weeks.

"You shouldn't have to put your life on hold to treat your allergies," Dr. Richard Weber, ACAAI vice president, said in a college news release. "Accelerated schedules offer patients more flexibility, faster results and a treatment plan they are more likely to follow because it reflects their needs and busy lifestyle."

"Research shows accelerated schedules are safe and effective options, and they appeal to patients who do not want to commit to weekly allergy shots for five or six months," he added.

Not only is allergy immunotherapy highly effective, it can save thousands of dollars in health care costs per patient, according to a study presented at the meeting.

Researchers examined Florida Medicaid data and found that children with allergies who received allergy immunotherapy had nearly $6,000 less in health care costs over 18 months than children with allergies who did not receive allergy immunotherapy. Among adults, the amount saved over 18 months was more than $7,000.

Because this research was presented at a medical meeting, the data and conclusions should be viewed as preliminary until published in a peer-reviewed journal.

"Allergy immunotherapy is a well-established, safe and effective treatment. Our research clearly shows that this treatment is also cost effective and these cost benefits occur almost immediately," Cheryl Hankin, president and chief scientific officer of BioMedEcon, said in the news release.

More information

The American Academy of Family Physicians has more about allergy shots.

-- Robert Preidt

SOURCE: American College of Allergy, Asthma and Immunology, news release, Oct. 27, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New research on improved treatment options and screening strategies for Hepatitis C
2. Thyroid Surgery Linked to Improved Sleep Apnea Symptoms
3. New oncolytic virus shows improved effectiveness in preclinical testing
4. Public reporting hasnt improved transplant centers care
5. Improved method for detecting mutant DNAs
6. Researchers from Boston University receive grant to develop improved virus detection system
7. Toward an improved test for adulterated heparin
8. Improved radical surgery techniques provide positive outcomes for bladder cancer patients
9. Clinic demonstrates improved quality of care resulting in cost savings for Medicare
10. New high-speed 3-D imaging system holds potential for improved cancer screening
11. New study may lead to quicker diagnosis, improved treatment for fatal lung disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Improved Allergy Shots Might Be on Horizon 
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology: